Warby Parker (WRBY) Total Current Liabilities (2020 - 2026)
Warby Parker (WRBY) reported Total Current Liabilities of $153.3 million for Q1 2026, up 25.01% on a YoY basis from $122.6 million in Q1 2025, and up 2.1% quarter-over-quarter from $150.1 million in Q4 2025.
Warby Parker (WRBY) Total Current Liabilities (2020 - 2026) Analysis & Trends
Warby Parker has reported Total Current Liabilities for 7 years, with the latest figure at $153.3 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 25.01% year-over-year to $153.3 million; the trailing twelve-month figure through Mar 2026 stood at $153.3 million (up 25.01% YoY), and the FY2025 full-year result was $150.1 million, up 15.17% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $153.3 million, up from $150.1 million in the prior quarter.
- The five-year high for Total Current Liabilities was $153.3 million in Q1 2026, with the low at $110.4 million in Q2 2023.
- Historically, Total Current Liabilities has averaged $126.7 million across 5 years, with a median of $127.1 million in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities fell 17.02% — and 2026, when it advanced 25.01%.
- Warby Parker's Total Current Liabilities stood at $129.6 million in 2022, then declined by 1.9% to $127.1 million in 2023, then grew by 2.57% to $130.4 million in 2024, then climbed by 15.17% to $150.1 million in 2025, then rose by 2.1% to $153.3 million in 2026.
- The last three Total Current Liabilities figures came in at $153.3 million (Q1 2026), $150.1 million (Q4 2025), and $132.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Warby Parker | 3.11 Bn | 2.82 Bn | 131.04 Mn | 153.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 153.28 Mn |
| Dec 31, 2025 | 150.13 Mn |
| Sep 30, 2025 | 132.07 Mn |
| Jun 30, 2025 | 135.53 Mn |
| Mar 31, 2025 | 122.61 Mn |
| Dec 31, 2024 | 130.35 Mn |
| Sep 30, 2024 | 130.12 Mn |
| Jun 30, 2024 | 121.03 Mn |
| Mar 31, 2024 | 118.54 Mn |
| Dec 31, 2023 | 127.09 Mn |
| Sep 30, 2023 | 121.81 Mn |
| Jun 30, 2023 | 110.43 Mn |
| Mar 31, 2023 | 111.04 Mn |
| Dec 31, 2022 | 129.56 Mn |
| Sep 30, 2022 | 111.48 Mn |
| Jun 30, 2022 | 119.86 Mn |
| Mar 31, 2022 | 128.74 Mn |
| Dec 31, 2021 | 118.10 Mn |
| Sep 30, 2021 | 134.36 Mn |
| Dec 31, 2020 | 105.33 Mn |